IDAS Reports

Virginia Tobacco Settlement Foundation

Drug Policy Series, No. 1 [pdf]

Publications for 2004 - 2005 | Publications for 2003 - 2004 | Publications for 2002 - 2003

IDAS Faculty Publications for July 2003 to June 2004

Aceto, M.D., Bowman, E.R., Harris, L.S. and May, E.L. (2003). Dependence studies of new compounds in the rhesus monkey, mouse and rat. Proceedings of College on Problems of Drug  Dependence, NIDA Research Monograph. 183:191 – 227.

Aceto, M.D., Bowman, E.R., Harris, L.S. and May, E.L. (2004). Dependence studies of new compounds in the rhesus monkey, mouse and rat. Proceedings of College on Problems of Drug  Dependence, NIDA Research Monograph. 184:170 – 204.

Agrawal, A., Neale, M.C., Jacobson, K.C., Prescott, C.A. and Kendler,  K.S. (2004). A twin study of illicit drug use and abuse/dependence: Modeling of the two-stage conditional relationship. Twin Research. 7:72 – 81.

Agrawal A., Neale, M.C., Prescott, C.A. and Kendler, K.S. (2004). Cannabis and other illicit drugs: Comorbid use and abuse/ dependence in males and females. Behavior Genetics. 34:217 – 228.

Agrawal, A., Prescott, C.A. and Kendler, K.S. (2004). Forms of cannabis and cocaine: A twin study. American Journal of Medical Genetics. 129:125 – 128.

Balster, R.L. (2003). Segment in teaching video presentation on The Importance of Laboratory Animal Research in Psychology: Psychopharmacology. Washington, D.C.: American Psychological Association.

Balster, R.L. and Jaffe, J.H. (2004). (published anonymously). Conversation with Charles R. Schuster. Addiction. 99:667 – 676.

Baskfield, C.Y., Martin, B.R. and Wiley, J.L. (2004). Differential effects of delta-tetrahydrocannabinol and methanandamide on operant behavior in CB1 knockout and wild type mice. Journal of Pharmacology and Experimental Therapeutics. 309:86 – 91.

Bass, C.E., Welch, S.P. and Martin, B.R. (2004). Reversal of  Delta(9) tetrahydrocannabinol-induced tolerance by specific  kinase inhibitors. European Journal of Pharmacology. 496(1 – 3):99 – 108.

Beardsley, P.M., Aceto, M.D., Cook, C.D., Bowman, E.R.,  Newman, J.L. and Harris, L.S. (2004). Discriminative stimulus,  reinforcing, physical dependence and antinociceptive effects of oxycodone in mice, rats and rhesus monkeys. Experimental  and Clinical Psychopharmacology. 12:163 – 172.

Blank, M.B., Koch, J.R. and Burkett, B.J. (2004). Less is more:  Virginia’s performance outcomes measurement system. Psychiatric Services. 55(6):643 – 645.

Blokhina, E.A., Dravolina, O.A., Bespalov, A.Y., Balster, R.L. and Zvartau, E.E. (2004). Intravenous self-administration of abused solvents and anesthetics in mice. European Journal of Pharmacology. 485:211 – 218.

Cabral, G.A. (2004). Cannabinoid-mediated exacerbation of brain infection by opportunistic amebae. Journal of Neuroimmunology. 147:127 – 130.

Carroll, I., Thomas, J.B., Dykstra, L.A., Granger, A.L., Allen, R.M., Howard, J.L., Pollard, G.T., Aceto, M.D. and Harris, L.S. (2004). Pharmacological properties of JDTic: A novel-opioid receptor  antagonist. European Journal of Pharmacology. 501:111 – 119.

Chang-Fong, J., Rangisetty, J.B., Dukat, M., Setola, V., Raffay, T., Roth, B. and Glennon, R.A. (2004). 1,2,3,4-tetrahydrocarbazoles as 5- HT6 serotonin receptor ligands. Bioorganic and Medicinal  Chemistry Letters. 14(8):1961 – 1964.

Chang-Fong, J., Tyacke, R.J., Lau, A., Westaway, J., Hudson, A.L. and  Glennon, R.A. (2004). Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands. Bioorganic and  Medicinal Chemistry Letters. 14(4):1003 – 1005.

Clement, A.B., Hawkins, E.G., Lichtman, A.H. and Cravatt, B.F. (2003). Increased seizure susceptibility and proconvulsant activity  of anandamide in mice lacking fatty acid amide hydrolase. The Journal of Neuroscience. 23:3916 – 23.

Cook, C.D., Newman, J.L., Winfree, J.C. and Beardsley, P.M. (2004). Blockade of the psychomotor stimulant effects of the noncompeti- tive NMDA receptor antagonist MK801 by D2/3 receptor agonists.  Pharmacology Biochemistry and Behavior. 77:309 – 318.

Cook, C.D. and Beardsley, P.M. (2004). Modulation of the discriminative stimulus effects of mu opioid agonists in rats: I. Effects of dopamine D2/3 antagonists. Behavioural Pharmacology. 15:65 – 74.

Cook, C.D. and Beardsley, P.M. (2004). Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II.  Effects of dopamine D2/3 agonists. Behavioural Pharmacology. 15:75 – 83.

Cox, M.L. and Welch, S.P. (2004). The antinociceptive effect of 9-THC in the arthritic rat. European Journal of Pharmacology. 493:65 – 74.

Cravatt, B.F. and Lichtman A.H. (2003). Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Current Opinion in Chemical Biology. 7:469 – 475.

Cravatt, B.F., Saghatelian, A., Hawkins, E.G., Clement, A.B., Bracey, M.H. and Lichtman, A.H. (2004). Functional disassociation of the central and peripheral fatty acid amide signaling system. Proceedings of the National Academy of Sciences. 101:10821 – 10826.

Cropsey, K., Eldridge, G. and Ladner, T. (2004). The results of a smoking survey among female prisoners: An ignored public health epidemic. Addictive Behaviors. 29:425 – 431.

Dalton, G.D., Smith, F.L. and Dewey, W.L. (2004). Effects of chronic  cannabinoid treatment on signal transduction systems in the mouse brain. International Cannabinoid Research Society, Paestum, Italy.

Dalton, G.D., Smith, F.L. and Dewey, W.L. (2004). Effects of chronic morphine administration on PKA kinetic activity in mouse brain. College on Problems of Drug Dependence, San Juan, PR.

Damaj, M.I., Kao, W. and Martin, B.R. (2003). Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. Journal of Pharmacology and Experimental Therapeutics. 307:526 – 534.

Damaj, M.I., Kuhar, M.J., Hunter, R.G. and Martin, B.R. (2003).  Antinociceptive effects of rat CART (55-102) peptide in acute and chronic pain models. Brain Research. 983: 233 – 236.

Damaj, M.I., Carroll, F.I., Eaton, B.J., Navarro, H.A., Blough, B.E.,  Mirza, S., Lukas, R.J., Martin, B.R. (2004). Enantioselective effects of hydroxymetablolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors. Molecular Pharmacology.

Dewey, W.L. (2003). College on Problems of Drug Dependence  2003: Proceedings of the 65th Annual Scientific Meeting,  NIDA Research Monograph. Vol. 184.

Dewey, W.L. and Harris, L.S. eds. (2003). College on Problems of Drug Dependence 2002: Proceedings of the 64th Annual Scientific Meeting. NIDA Research Monograph. Vol. 183.

Dewey, W.L., Smith, P.A. and Smith, F.L. (2004). Reversion of morphine tolerant mice into a non-tolerant state with PKC and PKA inhibitors. College on Problems of Drug Dependence, San Juan, PR.

Dewey, W.L., Welch, S.P., Martin, B.R., Razdan, R.K. and Smith, F.L. (2003). Behavioral tolerance and cross tolerance to D9-THC for anadamide and a stable analog of methanandamide, International Cannabinoid Research Society, Ontario, Canada.

Dogruer, D., Lee, M., Dukat, M., Damaj, M.I., Martin, B.R. and Glennon, R.A. (2004). 3-(4-aminobutyn-1-yl) pyridines:Binding at µ4b2 nicotinic cholinergic receptors. Bioorganic and Medicinal Chemistry Letters. 14:523 – 526.

Donny, E.C., Lanza, S.T., Balster, R.L., Collins, L.M., Caggiula, A., and Rowell, P.P. (2004). Using growth models to relate acquisition of nicotine self-administration to break point and  nicotine receptor binding. Drug and Alcohol Dependence. 75:23 – 35.

Dowdy, E. (2004). Health Impact of Tobacco Price Changes in Virginia. IDAS Drug Policy Series, No.1., Institute for Drug and Alcohol Studies, Virginia Commonwealth University, February.

Dukat, M., Smith, C., Herrick-Davis, K., Teitler, M. and Glennon, R.A. (2004). Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation. Bioorganic and  Medicinal Chemistry. 12(1):2545 – 2552.

Dukat, M., Taroua, M., Dahdouh, A., Siripurapu, U., Damaj, M.I.,  Martin, B.R. and Glennon, R.A. (2004). (+/-)8-Amino-5, 6, 7, 8-tetrahydroisoquinolines as novel antinociceptive agents. Bioorganic and Medicinal Chemistry Letters. 14(14):3651 – 3654.

Eckler, J.R., Chang-Fong, J., Rabin, R.A., Smith, C., Teitler, M., Glennon, R.A. and Winter, J.C. (2003). Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM. Pharmacology, Biochemistry, and Behavior. 75(4):845 – 852.

Eissenberg, T. (2004). Measuring the emergence of tobacco  dependence: The contribution of negative reinforcement models. Addiction. 99(1 Suppl):5 – 29.

Elliott, R.C., Miles M.F. and Lowenstein, D.H. (2003). Microarray  analysis of dentate gyrus gene expression indicates parallel  molecular mechanisms contribute to development- and epilepsy-associated neurogenesis and axon outgrowth. Journal of Neuroscience. 23:2218 – 2227.

Figueiredo, M.I., Fries, E., Ingram, K.M. (2004). The role of disclosure patterns and unsupportive social interactions in the well-being of breast cancer patients. Psychooncology. 13(2):96 – 105.

Forman, R., Svikis, D.S., Montoya, I. and Blaine, J. (2004). Selection of a substance use disorder diagnostic instrument by the national drug abuse treatment clinical trials network. Journal of Substance Abuse Treatment. 27(1):1 – 8.

Gerasimov, M.R., Collier, L., Ferrieri, A., Alexoff, D., Lee, D.,  Gifford, A.N. and Balster, R.L. (2003). Toluene inhalation produces a conditioned place preference in rats. European Journal of Pharmacology. 477:45 – 52.

Glennon, R.A., Daoud, M.K., Dukat, M., Teitler, M., Herrick- Davis, K., Purohit, A. and Syed, H. (2004). Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: A QSAR study. Bioorganic and Medicinal Chemistry. 11(20):4449 – 4454.

Glennon, R.A. and Dukat, M. (2004). Alpha4beta2 nACh receptor pharmacophore models. Bioorganic and Medicinal Chemistry Letters. 14(8):1841 – 1844.

Glennon, R.A., Dukat, M. and Liao, L. (2004). Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models. Current Topics in Medicinal Chemistry. 4(6):631 – 644.

Glennon, R.A., Grella, B., Tyacke, R.J., Lau, A., Westaway, J. and Hudson, A.L. (2004). Binding of an imidazopyridoindole at imidazoline I2 receptors. Bioorganic and Medicinal Chemistry Letters. 14(2):527 – 529.

Glennon, R.A., Grella, B., Tyacke, R.J., Lau, A., Westaway, J. and  Hudson, A.L. (2004). Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation. Bioorganic and  Medicinal Chemistry Letters. 14(4):999 – 1002.

Glennon, R.A., Ismaiel, A.M., Ablordeppey, S., El-Ashmawy, M.  and Fisher, J.B. (2004). Thioxanthene-derived analogs as  sigma(1) receptor ligands. Bioorganic and Medicinal Chemistry  Letters. 14(9):2217 – 2220.

Greiner, E., Spetea, M., Krassnig, R., Skullner, F., Aceto, M., Harris, L.S., Traynor, J.R., Woods, J.H., Coop, A. and Schmidhammer,  H. (2003). Synthesis and biological evaluation of 14-alkoxy- morphinans. 18.1 n-substituted 14-phenylpropyloxymorphinan- 6-ones with unanticipated agonist properties: Extending the  scope of common structure-activity relationships. Journal of  Medicinal Chemistry. 46:4182 – 4187.

Grella, B., Teitler, M., Smith, C., Herrick-Davis, K. and Glennon, R.A. (2003). Binding of beta-carbolines at 5-HT(2) serotonin  receptors. Bioorganic and Medicinal Chemistry Letters. 13(24):4421 – 4425.

Haller, D.L. and Miles, D.R. (2004). Drug dependent women: Psychopathology is associated with completion of residential treatment. Journal of Addictive Diseases. 23(1):17 – 28.

Haller, D.L. and Miles, D.R. (2004). Personality disturbances in drug dependent women: Relationship to childhood abuse. American Journal of Drug and Alcohol Abuse. 30:1 – 18.

Haller, D.L., Miles, D.R. and Cropsey, K. (2004). Smoking stage of change is associated with retention in a smoke-free residential drug treatment program for women. Addictive Behaviors. 29:1265 – 1270.

Hassan, S., Duong, B., Kim, K-S and Miles, M.F. (2003). Pharmacogenomic analysis of mechanisms underlying ethanol regulation of dopamine b-hydroxylase. Journal of Biological  Chemistry. 278:38860 – 38869.

Hettema, J.M., Prescott, C.A. and Kendler, K.S. (2003). The effects of anxiety, substance use and conduct disorders on risk of major depressive disorder. Psychological Medicine. 33:1423 – 1432.

Hoffman, P.L., Miles, M.F., Edenberg, H.J., Sommer, W., Tabakoff, B., Wehner, J.M. and Lewohl, J. (2003). Gene expression in brain: A window on ethanol dependence, neuroadaptation, and  preference. Alcoholism: Clinical and Experimental Research. 27:155 – 68.

Ingersoll, K. (2003). Project CHOICES Intervention Research Group. Feasibility of a motivational intervention to reduce the risk of alcohol exposed pregnancy. Pediatrics. 111(5):1131 – 1135.

Ingersoll, K.S. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV medication. AIDS Care. 16(2):199 – 211.

Ingersoll, K.S., Knisely, J.S., Dawson, K.S. and Schnoll, S.H. (2004). Psychopathology and treatment outcome of perinatal drug-dependent women. Addictive Behaviors. 29:731 – 741.

Jansson, L.M., Svikis, D.S., Beilenson, P. (2003). Effectiveness of child case management services for offspring of drug-dependent women. Substance Use and Misuse. 38(14):1933 – 52.

Javed, R.R., Dewey, W.L., Smith, P.A. and Smith, F.L. (2004). PKC and PKA inhibitors reverse tolerance to morphine-induced hypothermia and supraspinal analgesia in mice. European Journal of Pharmacology. 492:149 – 157.

Kendler, K.S., Jacobson, K.C., Prescott, C.A. and Neale, M.C. (2003). Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants and opiates in male twins. American Journal of Psychiatry. 160:687 – 695.

Kendler, K.S., Liu, X.Q., Gardner, C.O., McCullough, M.E., Larson, D. and Prescott, C.A. (2003). The dimensions of religiosity and their relationship to lifetime psychiatric and substance use disorders. American Journal of Psychiatry. 160:496 – 503.

Kendler, K.S., Prescott, C.A., Myers, J. and Neale, M.C. (2003). The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Archives of General Psychiatry. 60:929 – 937.

Kerns, R., Zhang, L. and Miles, M.F. (2003). Application of the S-score algorithm for analysis of oligonucleotide microarrays. Methods. 31:274 – 281.

Khorana, N., Smith, C., Herrick-Davis, K., Purohit, A., Teitler, M., Grella, B., Dukat, M., Glennon. R, A. (2003). Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors. Journal of Medicinal Chemistry. 46(18):3930 – 3937.

Khorana, N., Pullagurla, M.R., Dukat, M., Young, R. and Glennon, R.A. (2004). Stimulus effects of three sulfur containing psychoactive agents. Pharmacology, Biochemistry, and Behavior. 78(4):821 – 826.

Khorana, N., Pullagurla, M.R., Young, R. and Glennon, R.A.  (2004). Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: Asymmetric generalization. Drug and Alcohol Dependence. 74(3):281 – 287.

Kissin, W., Svikis, D.S., Moylan, P., Haug, N.A. and Stitzer, M. (2004). Identifying pregnant women at risk for early attrition from substance abuse treatment. Journal of Substance Abuse Treatment. 27(1):31 – 38.

Kliewer, W., Cunningham, J.N., Diehl, R., Parrish, K.A., Walker,  J.M., Atiyeh, C., Neace, B., Duncan, L., Taylor, K. and Mejia, R. (2004). Violence exposure and adjustment in inner-city  youth: Child and caregiver emotion regulation skill, caregiver-child relationship quality, and neighborhood cohesion as protective factors. Journal of Clinical Child and Adolescent Psychology. 33: 477 – 487.

Kliewer, W., Wade, N.G. and Worthington, E.L., Jr. (2003). Religion and spirituality in children: Preventing dysfunction  and promoting health. In T.P. Gullotta & M. Bloom (Eds), The Encyclopedia of Primary Prevention and Health  Promotion. New York: Plenum.

Kliewer, W., Wade, N.G. and Worthington, E.L., Jr. (2003).  Religion and spirituality in adolescents: Preventing dysfunction and promoting health. In T.P. Gullotta & M. Bloom (Eds), The Encyclopedia of Primary Prevention and Health Promotion. New York: Plenum.

Lanza, S.T., Donny, E.C., Collins, L.M. and Balster, R.L. (2004).  Analyzing the acquisition of nicotine self-administration using  growth curve models. Drug and Alcohol Dependence. 75: 11 – 21.

Lester, H.A., Fonck, C., Tapper, A.R., McKinney, S., Damaj, M.I., Balogh, S., Owens, J., Wehner, J.M., Collins, A.C., Labarca, C. (2003). Hypersensitive knock in mouse strains identify receptors and pathways for nicotine action. Current Opinion Drug Discovery Development. 5:633 – 639.

Lichtman, A.H., Shelton, C.C., Advanti, T., Cravatt, B.F. (2004). Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain. 109:319 – 327.

Maes, H.H., Sullivan, P.F., Bulik, C.M., Neale, M.C., Prescott, C.A., Eaves, L.J. and Kendler, K.S. (2004). A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychological Medicine. 34:1 – 11.

Marciano-Cabral, F. and Cabral, G.A. (2003). Acanthamoeba spp. As agents of disease in humans. Clinical Microbiology Reviews. 16:273 – 307.

Marciano-Cabral, F., Ludwick, C. and Cabral, G. A. (2003). Differential cytokine gene expression elicited by Acanthamoeba spp. and Balamuthia mandrillaris. In: Xth International Meeting on the Biology and Pathogenicity of Free-Living Amoebae Proceedings (Lares-Villa, F., Booton, G. C., and Marciano-Cabral, F., eds.). ITSON-DIEP, Cd. Obregon, Sonora, Mexico. pp. 143 – 154.

Marciano-Cabral, F., Ludwick, C., Puffenbarger, R. A. and Cabral, G. A. (2004). Differential stimulation of microglial pro-inflammatory cytokines by acanthamoeba culbertsoni versus acanthamoeba castellanii. Journal of Eukaryotic Microbiology. 51(4):472 – 479.

Marciano-Cabral, H.K., Powell, E., Ferguson, T. and Cabral, G. (2003). Interaction of an acanthamoeba human isolate harboring bacteria with murine peritoneal macrophages. Journal of Eukaryotic Microbiology. 50:516 – 519.

Martin, B.R. (2004). Neurobiology of Marijuana. In: Textbook of Substance Abuse Treatment Third Edition, Galanter, M. and Kleber, H.D., (eds), American Psychiatric Press. pp. 59 – 68.

Martin, B.R. and Dewey, W.L. (2004). Contemporary Drug Abuse in Modern Pharmacology with Clinical Applications, Sixth Edition, Craig C.R. and Stitzel, R.E. (eds), Lippincott Williams  & Wilkins, Maryland. 406 – 422.

Martin, B.R., Sim-Selley, L.J. and Selley, D. (2004). Signaling  pathways involved in the development of cannabinoid tolerance. Trends in Pharmacological Science. 25: 6.

May, E.L., Coop, A., Woods, H.H., Aceto, M.D., Bowman, E.R., Harris, L.S. and Traynor, J.R. (2003). N-(Trifluoromethyl) benzyl substituted N-normetazocines and N-norketobemidones, Bioorganic and Medicinal Chemistry. 11:31 – 33.

Maziak, W., Asfar, T., Rastam, S., Hammal, F., Eissenberg, T., Bachir, M.E., Fouad, M.F. and Ward, K.D. (2004). Gender and smoking status-based analysis of views regarding waterpipe and cigarette smoking in Aleppo, Syria. Preventive Medicine. 38:479 – 484.

Maziak, W., Eissenberg, T., Klesges, R.C., Kiel, U. and Ward, K.D. (2004). Adapting Smoking Cessation Interventions for Developing  Countries: A Model for the Middle East. International Journal of Tuberculosis and Lung Disease. 8:403 – 413.

Maziak, W., Fouad, M.F., Asfar, T., Hammal, F., Bachir, M.E., Rastam, S., Eissenberg, T. and Ward, K.D. (2004). Prevalence and characteristics of narghile smoking among university students in Aleppo, Syria. International Journal of Tuberculosis and Lung Disease. 8:882 – 889.

Maziak, W., Rastam, S., Asfar, T., Hammal, F., Eissenberg, T., Bachir,  M.E., Fouad, M.F. and Ward, K.D. (2004). Characteristics of cigarette smoking and quitting among university students in Syria.  Preventive Medicine. 39:330 – 336.

Maziak, W., Ward, K.D. and Eissenberg, T. (2004). Factors related  to frequency of narghile (waterpipe) use: The first insights on  tobacco dependence in narghile users. Drug and Alcohol Dependence. 76(1):101 – 106.

Maziak, W., Ward, K.D., Eissenberg, T., Klesges, R.C. and Keil, U.  (2004). The Syrian Center for Tobacco Studies: a model of international partnership for the creation of a sustainable research basis in developing countries. Promotion and Education. 11:29 – 33.

McCance-Katz, E.F. and Clark, H.W. (2004). Key Readings in  Addiction Psychiatry: Psychosocial Treatments. Taylor and Francis, Philadelphia, PA.

McCance-Katz, E.F., Rainey, P., Smith, P., Morse, G., Friedland, G., Gourevitch, M. and Jatlow, P. (2004). Drug interactions between opioid and antiretroviral medications: Interaction between methadone, LAAM, and nelfinavir. American Journal on Addictions. 13:163 – 180.

Mechoulam, R. and Lichtman, A.H. (2003). Neuroscience Perspective: Stout guards of the central nervous system. Science. 302:65 – 67.

Nicholson, K.L., Balster, R.L. (2003). Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats. Psychopharmacology (Berlin). 170:215 – 24.

Obando, C.P., Kliewer, W., Murrelle, L. and Svikis, D.S. (2004). The comorbidity of substance abuse and depressive symptoms in Costa Rican adolescents. Drug and Alcohol Dependence.

Olson, J.M., Kennedy, S.J. and Cabral, G.A. (2003). Expression of the murine CB2 cannabinoid receptor using a recombinant  Semliki Forest virus. Biochemical Pharmacology. 65:1931 – 1942.

Ozer, E.J., Richards, M.H and Kliewer, W. (2004). Introduction to  the special section on protective factors in the relation between community violence exposure and adjustment in youth. Journal  of Clinical Child and Adolescent Psychology. 33:434 – 438.

Peddi, S., Roth, B.L., Glennon, R.A. and Westkaemper, R.B. (2003). Spiro[9,10 –dihydroanthracene]-9,3’-pyrrolidine-a July 2, 2008 European Journal of Pharmacology. 482(1 – 3):335 – 337.

Peddi, S., Roth, B.L., Glennon, R.A. and Westkaemper, R.B. (2004). Structural determinants for high 5-HT(2A) receptor  affinity of spiro[9,10-dihydroanthracene]-9,3(’)-pyrrolidine  (SpAMDA). Bioorganic and Medicinal Chemistry Letters.  14(9):2279 – 2283.

Peterson, P.K., Gekker, G., Hu, S., Cabral, G. and Lokensgard, J.R. (2004). Cannabinoids and morphine differentially affect HIV-1 expression in CD4+ lymphocyte and microglial cell cultures.  Journal of Neuroimmunology. 147:123 – 126.

Prescott, C.A., Cross, R.J., Kuhn, J.W., Horn, J.L. and Kendler, K.S. (2004). Are genetic influences on risk for alcoholism mediated by individual differences in motivations for drinking? Alcoholism: Clinical and Experimental Research. 28:12 – 23.

Prescott, C.A. and Kendler, K.S. (2003). Early smoking and risk for illicit drug use. Using data from twins to evaluate the tobacco gateway hypothesis. Behavior Genetics. 33:714.

Prisinzano, T., Dukat, M., Law, H., Slassi, A., MacLean, N., DeLannoy, I. and Glennon, R.A. (2004). 2-(Anilino) imidazolines and 2-(benzyl)imidazoline derivatives as h5- HT1D serotonin receptor ligands. Bioorganic and Medicinal Chemistry Letters. 14(18):4679 – 4699.

Pullagurla, M., Bondareva, T., Young, R. and Glennon, R.A. (2004). Modulation of the stimulus effects of (+)amphetamine by the 5-HT6 antagonist MS-245. Pharmacology, Biochemistry, and Behavior. 78(2):263 – 268.

Pullagurla, M.R., Dukat, M., Setola, V., Roth, B. and Glennon, R.A. (2003). N1-benzenesulfonylgramine and N1-benze nesulfonylskatole: novel 5-HT6 receptor ligand templates.  Bioorganic and Medicinal Chemistry Letters. 13(19):3355 – 3359.

Pullagurla, M.R., Westkaemper, R.B. and Glennon, R.A. (2004). Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors. Bioorganic and Medicinal Chemistry Letters. 14(17):4569 – 4573.

Quillin, J.M., Fries, E., McClish, D., Shaw de Paredes, E., Bodurtha, J. (2004). Gail model risk assessment and risk perceptions. Behavioral Medicine. 27(2):205 – 14.

Rahman, Z., Schwarz, J., Gold, S.J., Wein, M.N., Choi, K.H., Kovoor, A., Chen, C.K., DiLeone, R., Schwarz, S.C., Barrot, M., Luedtke, R.R., Sim-Selley, L.J., Selley, D.E., Self, D., Neve, R.L.,  Lester, H.A., Simon, M.I. and Nestler, E.J. (2003). RGS9 modulates dopamine signaling in the basal ganglia. Neuron. 38:941 – 952.

Rastam, S., Ward, K.D., Eissenberg, T. and Maziak, W. (2004).  Estimating the beginning of the waterpipe epidemic in Syria. BMC Public Health. 4:32.

Rice, A.C, Bullock, M.R. and Shelton, K.L. (2004). Chronic ethanol consumption transiently reduces adult neural progenitor cell proliferation. Brain Research. 1011:94 – 98.

Rothman, R.B., Vu, N., Partilla, J.S., Roth, B.L., Hufeisen, S.J., Compton-Toth, B.A., Birkes, J., Young, R. and Glennon, R.A. (2003). In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. Journal of Pharmacology and Experimental Therapeutics. 307(1):138 – 145.

Schnoll, S.H. and Weaver, M.F. (2003). Addiction and Pain. American Journal on Addictions. 12:S27 – S35.

Schnoll, S.H. and Weaver, M.F. (2004). Phencyclidine and  Ketamine. In M. Galanter and H.D. Klebert (Eds), Textbook of Substance Abuse Treatment, Third Edition. Washington, D.C.: American Psychiatric Press, pp. 211 – 215.

Schutz, J., Spetea, M.F., Koch, M., Aceto, M.D., Harris, L.S., Coop, A. and Schmidhammer, H. (2003). Synthesis and biological evaluation of 14-alkoxymorphinans. 20.1 14-phenylpropyloxymetopon: An  extremely powerful analgesic. Journal of Medicinal Chemistry 46:4182 – 4187.

Schwindinger, W.F., Giger, K.E., Betz, K.S., Stauffer, A.M., Sunderlin, E.M., Sim-Selley, L.J., Selley, D.E., Bronson, S.K. and Robishaw, J.D. (2004). Mice with deficiency of G-protein 3 are lean and have seizures. Molecular Cellular Biology. 24:7758 – 7768.

Selley, D.E., Cassidy, M.P., Martin, B.R. and Sim-Selley, L.J. (2004). Chronic administration of 9-THC desensitizes CB1-, adenosine  A1- and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum. Molecular Pharmacology. 66(5):1275 – 1284.

Shannon, E.E., Shelton, K.L., Vivian, J.A., Yount, I., Morgan A.R., Homanics, G.E. and Grant, K.A. (2004). Discriminative stimulus effects of ethanol in mice lacking the GABAA receptor delta subunit. Alcoholism: Clinical and Experimental Research. 28:906 – 913.

Simsek, R., Chang-Fong, J., Lee, M., Dukat, M., Damaj, M., Martin, B. and Glennon, R. (2003). Quaternary ammonium 3-(Aminoethoxy) pyridines as antinociceptive agents. Bioorganic and Medicinal Chemistry Letters. 13:2917 – 2920.

Sim-Selley, L.J. (2003). Regulation of cannabinoid CB1 receptors by chronic cannabinoids. Critical Reviews in Neurobiology. 15(2):1 – 30.

Slattum, P.W., Ramchandani, V.A. and Venitz, J. (2004). Lack Of Development Of Acute Tolerance (AT) To Intravenous (IV) Ethanol (ETH) In The Elderly (abstract). Presented as a podium presentation at the 105th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Miami Beach, FL.

Slattum, P.W. and Venitz, J. Clinical Pharmacokinetics in the  Elderly. In: Figg W.D. and McLeod H.L. (2004). Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Totowa, NJ: Humana Press, Inc., 421 – 430.

Smith, F.L., Javed, R.R., Elzey, M.J. and Dewey, W.L. (2003). The  expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA. Brain Research. 985:75 – 88.

Smith, F.L., LeBlanc, S.J., Carter, R. (2004). Influence of intracellular Ca2+ release modulating drugs on bupivacaine infiltration anesthesia in mice. European Journal of Pain. 8:153 – 61.

Smith, F.L., Seager, E., Scoggins, K. and Dewey, W.L. (2004). Effects of chronic cannabinoid treatment on the phosphatidylinositol cascade in mouse brain. International Cannabinoid Research Society, Paestum, Italy.

Smith, F.L., Smith, P.A. and Dewey, W.L. (2004). Reversal of morphine tolerance in mice with PKC pseudosubstrate inhibitors. College on Problems of Drug Dependence, San Juan, PR.

Smith, F.L., Smith, P.A., Dewey, W.L. and Javed, R.R. (2004). Effects of mGlu1 and mGlu5 metabotropic glutamate antagonists to reverse morphine tolerance in mice. European Journal of Pharmacology. 492:137 – 142.

Sobell, M.B., Sobell, L.C., Johnson, K., Velasquez, M.M., Mullen, P.D., von Sternberg, K., Nettleman, M.D., Ingersoll, K.S. and Ceperich, S.D., Project CHOICES Intervention Research Group, Rosenthal, J., Floyd, R.L., and Sidhu, J.S. (2003). Motivational intervention to reduce alcohol-exposed pregnancies- Florida, Texas, and Virginia, 1997 – 2001. Morbidity and Mortality Weekly Reports, 52, No. 18, May 9 – 16.

Spetea, M.F., Schullner, F., Moisa, R.C., Berzetei-Gurske, I.P., Schraml, B., Dorfler, C., Aceto, M.D., Harris, L.S., Coop, A. and Schmidhammer, H. (2004). Synthesis and biological evaluation of 14-alkoxymorphinans. 21. novel 4-alkoxy and 14-ohenylpropyl derivatives of the mu opioid receptor antagonist  cyprodime: Journal of Medicinal Chemistry. 47:3242 – 3247.

Stanton, C.A., Fries, E.A., Danish, S.J. (2003). Racial and gender  differences in the diets of rural youth and their mothers. American Journal Health Behavior. 27(4):336 – 47.

Sullivan, P.F., Neale, B., van den Oord, E., Miles, M.F., Neale,  M.C., Bulik, C.M., Joyce, P.R., Kendler, K.S. and Straub, R.E. (2004). Candidate Genes for nicotine dependence via linkage, epistasis, and bioinformatics. American Journal of Medical Genetics. 126B:23 – 36.

Svikis, D.S., Reid-Quinones, K. (2003). Screening and prevention of alcohol and drug use disorders in women. Obstetric and Gynecology Clinical North America. 30(3):447 – 68. Review.

Thompson, C.M., Wojno, H., Greiner, E., May, E.L., Rice, K.C. and Selley, D.E. (2004). Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors. Journal of Pharmacology and Experimental Therapeutics. 308:547 – 554.

Tuten, M., Jones, H.E., Tran, G. and Svikis, D.S. (2004). Partner violence impacts the psychosocial and psychiatric status of pregnant, drug-dependent women. Addictive Behaviors. 29(5):1029 – 1034.

Tyacke, R.J., Lau, A., Grella, B., Glennon, R.A., Nutt, D.J. and Hudson, A.L. (2003). Investigation of the affinities of two new beta-carbolines for rat brain imidazoline(2) receptors. Annals of the New York Academy of Sciences. 1009:361 – 363.

Wade, N.G., Worthington, E.L. and Kliewer, W. (2003). Religion and spirituality in adults: Preventing dysfunction and promoting health In T.P. Gullotta and M. Bloom (Eds), The Encyclopedia of Primary Prevention and Health Promotion. New York: Plenum.

Wade, N.G., Worthington, E.L. and Kliewer, W. (2003). Religion and spirituality in older adults: Preventing dysfunction and promoting health. In T.P. Gullotta and M. Bloom (Eds), The  Encyclopedia of Primary Prevention and Health Promotion. New York: Plenum.

Wallace, M.J., Blair, R.E., Falenski, K.W., Martin, B.R. and  DeLorenzo, R.J. (2003). The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. Journal of Pharmacology and Experimental Therapeutics. 307:129 – 137.

Weaver, M.F. (2003). Perinatal Addiction. In A.W. Graham and  T.K. Shultz (Eds), Principles of Addiction Medicine, 3rd Ed., Chevy Chase, MD: American Society of Addiction Medicine, Inc., pp. 1231 – 1246.

Weaver, M.F. (2003). Heroin and other opioids. In B. D. Rose (Ed),  Up To Date, Up To Date, Wellesley.

Weaver, M.F. (2004). Sedative and stimulant abuse in adults. In B. D. Rose (Ed), Up To Date, Up To Date, Wellesley.

Weaver, M.F. (2004). Hallucinogen and inhalant abuse in adults. In B. D. Rose (Ed), Up To Date, Up To Date, Wellesley.

Weaver, M.F. (2004). Marijuana. In B.D. Rose (Ed), Up To Date, Up To Date, Wellesley.

Weaver, M.F., Hoffman, H.J., Johnson, R.E. and Mauck, K.L.  (2003). Symptom-triggered versus fixed-schedule dosing for alcohol withdrawal in general medicine patients. Journal of  Addictive Diseases. 22:138.

Weaver, M.F., Jarvis, M.A. and Schnoll, S.H. (2004). Overview of the recognition and management of the drug abuser. In B.D.  Rose (Ed), Up To Date, Up To Date, Wellesley.

Welch, S.P. (2004). Neurobiology of cannabinoids. In: Substance  Abuse: A Comprehensive Textbook, Fourth Edition. J.H.  Lowenstein, P. Ruiz, R. B. Millman and J.G. Langrod (eds).

Welch, S.P. and Martin, B.R. (2003). The pharmacology of marijuana. In: Principles of Addiction Medicine, Third edition, American Society of Addiction Medicine, pp. 249 – 270.

Welch, S.P. and Martin, B.R. (2004). Chapter 26. Opioid and nonopioid analgesics. In: Modern Pharmacology, sixth edition, Craig, C.R. and Stitzel, R.E. (eds), Lippincott Williams & Wilkins, Maryland.

West, J.C., Kosten, T., Wilk, J., Svikis, D.S., Triffleman, E., Rae,  D.S., Narrow, W.E., Duffy, F.F. and Regier, D.A. (2004). Challenges in increasing access to buprenorphine treatment for opiate addiction. American Journal on Addictions. 13(1 Sppl): S8 – 16.

Whitlow, C.T., Liguori, A., Livengood, B.L., Hart, S.L., Mussat- Whitlow, B.J., Lamborn, C.M., Laurienti, P.J. and Porrino, L.J. (2004). Long-term heavy marijuana users make costly decisions on a gambling task. Drug and Alcohol Dependence. 76(1):107 – 111.

Wiley, J.L. and Balster, R.L. (2004). Effects of modulators of N-methyl-D-aspartate receptor-mediated neurotransmission on diazepam discrimination in rats. Life Sciences. 75:141 – 151.

Wiley, J.L., Harvey, S.A., Balster, R.L. and Nicholson, K.L. (2003). Affinity and specificity of N-methyl-D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of  acoustic startle in rats. Psychopharmacology. 165:378 – 385.

Wilson, D.K., Kliewer, W. and Sica, D.A. (2004). The relationship between violence exposure and blood pressure mechanisms. Current Hypertension Reports. 6:321 – 326.

Zachariou, V., Georgescu, D., Sanchez, N., DiLeone, R., Neve, R.L., Simon, M.I., Sim-Selley, L.J., Gold, S.J., Selley, D.E. and Nestler, E.J. (2003). Essential role for RGS9-2 in opiate  action. Proceedings of the National Academy of Sciences of the United States of America. 100:13656 – 13661.

Zhang, L., Miles, M.F. and Adape, K.D. (2003). A model of molecular interactions on short oligonucleotide microarrays. Nature Biotechnology. 21:818 – 821.